Abstract:Ferroptosis is a type of iron-dependent, non-apoptotic cell death, which is typically induced by cysteine starvation or by the inhibition of glutathione peroxidase 4 (GPX4) activity with the accompanying elevation in lipid peroxidation product levels. Despite the central role of mitochondria in oxidative metabolism and hence, as main sources of superoxide, the issue of whether mitochondrial superoxide participates in the execution of ferroptosis remains unclear. To gain additional insights into this issue, we employed suppressors of the site IQ electron leak (S1QEL) and suppressors of the site IIIQo electron leak (S3QEL), small molecules that suppress mitochondrial superoxide production from complex I and III, respectively. The findings indicate that S3QEL, but not S1QEL, significantly protected mouse hepatoma Hepa 1-6 cells from lipid peroxidation and the subsequent ferroptosis induced by cysteine (Cys) starvation (cystine deprivation from culture media or xCT inhibition by erastin). The intracellular levels of Cys and GSH remained low irrespective of life or death. Moreover, S3QEL also suppressed ferroptosis in xCT-knockout mouse-derived embryonic fibroblasts, which usually die under conventional cultivating conditions due to the absence of intracellular Cys and GSH. Although it has been reported that erastin induces the hyperpolarization of the mitochondrial membrane potential, no correlation was observed between hyperpolarization and cell death in xCT-knockout cells. Collectively, these results indicate that superoxide production from complex III plays a pivotal role in the ferroptosis that is induced by Cys starvation, suggesting that protecting mitochondria is a promising therapeutic strategy for the treatment of multiple diseases featuring ferroptosis.

Repression of ferroptotic cell death by mitochondrial calcium signaling

Peroxisome proliferator-activated receptor δ rescues xCT-deficient cells from ferroptosis by targeting peroxisomes

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

The mitochondrial regulation in ferroptosis signaling pathway and its potential strategies for cancer

Negative modulation of mitochondrial calcium uniporter complex protects neurons against ferroptosis

Correction: Mitochondrial Regulation of GPX4 Inhibition–mediated Ferroptosis in Acute Myeloid Leukemia

Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers

Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway

Mitochondria as multifaceted regulators of ferroptosis

CGI1746 Targets Σ1r to Modulate Ferroptosis Through Mitochondria-Associated Membranes

Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway

A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria

Mitochondrial Carrier 1 (MTCH1) Governs Ferroptosis by Triggering the FoxO1-GPX4 Axis-Mediated Retrograde Signaling in Cervical Cancer Cells.

CGI1746 targets σ 1 R to modulate ferroptosis through mitochondria-associated membranes

Leveraging tumor cell ferroptosis for colorectal cancer treatment via nanoelicitor-activated tumoricidal immunity

Role of mitochondria in the regulation of ferroptosis and disease

Ferroptosis as a target for protection against cardiomyopathy

Superoxide produced by mitochondrial complex III plays a pivotal role in the execution of ferroptosis induced by cysteine starvation

Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function

Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters

Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy